Sort
34,240 grants matching “atherosclerosis”
Selective Insulin Resistance- Diabetic Cardiovascular Diseases
$368,238George L King · Joslin Diabetes Center · R01 · FY2017 · DK
Selective Insulin Resistance- Diabetic Cardiovascular Diseases
$368,238George L King · Joslin Diabetes Center · R01 · FY2015 · DK
The Nerve Terminal as the Site of Action for Type-2 Alkenes
$368,235Richard Michael Lopachin · Albert Einstein College Of Medicine · R01 · FY2013 · ES
FAK regulation of cholesterol influx and efflux in foam cells
$368,232Steve Lim · University Of Alabama At Birmingham · R01 · FY2024 · HL
Role of PTEN in Vascular Lesion Formation
$368,181Mary Cm Weiser-Evans · University Of Colorado Denver · R01 · FY2012 · HL
Regulation of Lysosomes in Autophagy in Coronary Arterial Myocytes
$368,143Pin-Lan Li · Virginia Commonwealth University · R01 · FY2015 · HL
NO, SERCA, and Oxidative Stress in Atherosclerosis
$368,131Richard A Cohen · Boston University Medical Campus · R01 · FY2008 · HL
NO, SERCA, and Oxidative Stress in Atherosclerosis
$368,131Richard A Cohen · Boston University Medical Campus · R01 · FY2007 · HL
Macrophage-specific targeting of LXRs in CVD and NASH
$368,128Christopher K Glass · University Of California, San Diego · P01 · FY2022 · HL
Pivotal Role of Oxidation-specific Epitopes in CVD and NASH.
$368,126Joseph L Witztum · University Of California, San Diego · P01 · FY2022 · HL
PON2 and PON3 proteins in Atherosclerosis
$368,125University Of California Los Angeles · R01 · FY2003 · HL
Sympathetic Nerve Responsiveness and Pri Afferent Neurons with Femorail Artery Oc
$368,118Jianhua Li · Pennsylvania State Univ Hershey Med Ctr · P01 · FY2012 · HL
PAI-1 and Vitronectin in Failure of Coronary Revascularization
$368,107William P Fay · University Of Missouri-Columbia · R01 · FY2012 · HL
Training in Research on Vascular Inflammation and Injury
$368,076Sarah Y. Yuan · University Of South Florida · T32 · FY2024 · HL
A Comparative Effectiveness & Long-term Health Study in Wisconsin Smokers
$368,069Michael C Fiore · University Of Wisconsin-Madison · R01 · FY2013 · HL
Group V sPLA2 in Atherosclerosis
$368,063University Of Kentucky · R01 · FY2004 · HL
Creating Engineered Models of Valvular Disease to Study Anti-Calcific Therapies
$368,060Kristyn S Masters · University Of Wisconsin-Madison · R01 · FY2011 · HL
Regulation of Liver-Specific Gene Expression
$368,055Frances M Sladek · University Of California Riverside · R01 · FY2012 · DK
GENETIC CONTROL OF PROTEOGLYCAN METABOLISM
$368,026University Of California San Diego · R37 · FY2002 · GM
Bioengineering approaches to map mechanotransduction in the living cell
$368,026Ning Wang · University Of Illinois At Urbana-Champaign · R01 · FY2012 · GM
Social-biological predictors of heterogeneity in CVD risk in African Americans
$368,019Ana V Diez Roux · University Of Michigan At Ann Arbor · P60 · FY2016 · MD
Serum amyloid P and chronic noncommunicable diseases
$368,010Weibin Shi · University Of Virginia · RC1 · FY2010 · HL
The Role of Ceramide Kinase in Eicosanoid Synthesis
$368,008Charles E Chalfant · Virginia Commonwealth University · R01 · FY2010 · HL
The Role of Ceramide Kinase in Eicosanoid Synthesis
$368,008Charles E Chalfant · Virginia Commonwealth University · R01 · FY2011 · HL
Assembly and Trafficking of IK1 and SK3 in Endothelia
$367,995Daniel C Devor · University Of Pittsburgh At Pittsburgh · R01 · FY2012 · HL